Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Haefeli

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Clinical Pharmacology and Therapeutics|February 8, 2014
Response to "can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": evaluation of CYP3A activity with microdoses of midazolamN Hohmann, B Halama, N Siller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
Hair loss following typhoid fever: a forgotten phenomenonW E Haefeli, R Ott, A J Bircher, et al.
Archives of Internal Medicine|September 26, 2001
Risk of cataract in patients treated with statinsR G Schlienger, W E Haefeli, H Jick, et al.
Deutsche Medizinische Wochenschrift (1946)|August 4, 2009
[Information on medications - How do chronically ill patients assess counselling on drugs in general practice?]Cornelia Mahler, S Jank, K Hermann, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1991
Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothoraxR A Schoenenberger, W E Haefeli, P Weiss, et al.
The American Journal of Medicine|February 1, 1993
Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdoseW E Haefeli, R A Schoenenberger, P Weiss, et al.
The American Journal of Physiology|September 2, 1998
Human neuropeptide Y potentiates alpha1-adrenergic blood pressure responses in vivoL V Schuerch, L M Linder, E Grouzmann, et al.
BMJ (Clinical Research Ed.)|May 26, 1990
Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes)R A Schoenenberger, W E Haefeli, P Weiss, et al.
Pharmacy World & Science : PWS|July 31, 1999
Academic detailing improves identification and reporting of adverse drug eventsR G Schlienger, T F Lüscher, R A Schoenenberger, et al.
Deutsche Medizinische Wochenschrift (1946)|May 5, 2006
[Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model]T Bertsche, M Haas, H Oberwittler, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|February 8, 2014
Response to "can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": evaluation of CYP3A activity with microdoses of midazolamN Hohmann, B Halama, N Siller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
Hair loss following typhoid fever: a forgotten phenomenonW E Haefeli, R Ott, A J Bircher, et al.
Archives of Internal Medicine|September 26, 2001
Risk of cataract in patients treated with statinsR G Schlienger, W E Haefeli, H Jick, et al.
Deutsche Medizinische Wochenschrift (1946)|August 4, 2009
[Information on medications - How do chronically ill patients assess counselling on drugs in general practice?]Cornelia Mahler, S Jank, K Hermann, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1991
Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothoraxR A Schoenenberger, W E Haefeli, P Weiss, et al.
The American Journal of Medicine|February 1, 1993
Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdoseW E Haefeli, R A Schoenenberger, P Weiss, et al.
The American Journal of Physiology|September 2, 1998
Human neuropeptide Y potentiates alpha1-adrenergic blood pressure responses in vivoL V Schuerch, L M Linder, E Grouzmann, et al.
BMJ (Clinical Research Ed.)|May 26, 1990
Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes)R A Schoenenberger, W E Haefeli, P Weiss, et al.
Pharmacy World & Science : PWS|July 31, 1999
Academic detailing improves identification and reporting of adverse drug eventsR G Schlienger, T F Lüscher, R A Schoenenberger, et al.
Deutsche Medizinische Wochenschrift (1946)|May 5, 2006
[Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model]T Bertsche, M Haas, H Oberwittler, et al.
Pageof 14